Innovations in AI for Code Security and Drug Development

This chapter explores the use of machine learning for code vulnerability detection through QL rules, showcasing its efficiency. It also highlights a groundbreaking AI-driven drug by In Silico Medicine that is about to enter phase one trials for idiopathic pulmonary fibrosis, illustrating the future possibilities of AI in drug development.